Description
Myasthenia Gravis (MG) is a long-term muscle disease leading to muscle weakness of varying severity.
The measurement of autoantibodies against muscle-specific receptor tyrosine kinase (MuSK) supports the diagnosis of myasthenia gravis (MG)
The determination of autoantibodies against MuSK is used especially in patients who have tested negative for autoantibodies against the acetylcholine receptor (AChR, 70 % of AChR-Ab seronegative patients show autoantibodies against MuSK). The comprehensive detection of antibodies is necessary for the diagnosis and treatment of Myasthenia Gravis, therefore, the determination of MuSK antibodies and the determination of autoantibodies against Acetylcholine Receptor (AChR) is usually performed simultaneously.
